InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-37.2%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Fuhrman Alan, Director. Director active across 4 companies, notably SpringWorks Therapeutics, Inc.. In total, 15 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €140k. History available since 20 May 2021. The latest transaction was filed on 14 May 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations15 total
10,060 shares0Common StockSEC:0001104659-25-049658:0
1,238 shares@ US$9.7755.9% of flowCommon StockSEC:0000950170-25-041550:0
9,500 shares@ US$15.995273.8% of flowCommon StockSEC:0000950170-24-120099:0
Ideal exit: 27 Jul 2025 (T+270)
954 shares@ US$12.4785.6% of flowCommon StockSEC:0000950170-24-107391:0
23,000 shares0Common StockSEC:0001628280-24-025219:0
4,095 shares0Common StockSEC:0001104659-24-062978:0
932 shares@ US$12.4785.6% of flowCommon StockSEC:0000950170-24-033848:0
1,463 shares@ US$12.5035100.0% of flowCommon StockSEC:0001209191-23-050090:0
5,150 shares0Common StockSEC:0001628280-23-022461:0
4,648 shares0Common StockSEC:0001104659-23-064645:0
4,818 shares0Common StockSEC:0001104659-22-063507:0
12,376 shares0Common StockSEC:0001628280-21-011361:0
12,376 shares0Common StockSEC:0001628280-21-011361
1,106 shares0Common StockSEC:0001104659-21-070519
1,106 shares0Common StockSEC:0001104659-21-070519:0
15 of 15 declarations
About Fuhrman Alan
Alan Fuhrman is a Board Member at SpringWorks Therapeutics, Inc. and Esperion Therapeutics, Inc. With a solid background in the biopharmaceutical sector, he participates in strategic decision-making and oversight of the operations of these companies. His role as a board member allows him to provide valuable insights into market challenges and opportunities. Alan Fuhrman is committed to supporting the mission of these companies while ensuring sustainable development and growth.
